Navigation Links
Northwestern Memorial's Heart Center Pioneers Minimally Invasive Surgery That Corrects Irregular Heart Beat
Date:2/12/2008

es inserting several catheters, or tubes, into the heart and locating the abnormal electrical signals causing the atrial fibrillation. Once found, the pathway is destroyed with energy sources similar to those used in Stage I of the Hybrid Maze. Stage II targets areas of the heart that cannot be reached from the outside of the heart. For more information on the Bluhm Cardiovascular Institute, visit http://www.nmh.org/heart.

About Northwestern Memorial Hospital

Northwestern Memorial Hospital is one of the country's premier academic medical centers and is the primary teaching hospital of the Northwestern University Feinberg School of Medicine. Northwestern Memorial and its Prentice Women's Hospital and Stone Institute of Psychiatry have 897 beds along with 1,424 affiliated physicians and 6,464 employees. Northwestern Memorial is recognized for providing state-of-the-art patient care and exemplary clinical and surgical advancements in the areas of cardiothoracic and vascular care, gastroenterology, neurology and neurosurgery, oncology, organ and bone marrow transplantation, and women's health.

Northwestern Memorial received the prestigious 2005 National Quality Health Care Award and is listed in eight specialties in U.S. News & World Report's 2007 rankings for "America's Best Hospitals." For seven years running, Northwestern Memorial has been rated among the nation's "100 Best Companies for Working Mothers" by Working Mother magazine and has been chosen by Chicagoans for more than a decade as their "most preferred hospital" according to the National Research Corporation's annual survey. Northwestern Memorial carries the Magnet status designation in nursing, the highest recognition possible for patient care and nursing excellence.

###


'/>"/>
SOURCE Northwestern Memorial Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Royalty Pharma Acquires a Portion of Northwestern Universitys Royalty Interest in Lyrica(R) for $700 Million
2. Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study
3. Northwestern exposing most deadly infectious diseases in 3-D
4. Northwestern Memorial Hospital Completes Move Into Its New Prentice Womens Hospital
5. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
6. Evanston Northwestern Healthcare Wins Award For Patient Safety
7. New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment
8. New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health
9. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
10. Doctors uncertain about approaches to care for heart failure patients, SLU study finds
11. Dangerous duo: Hostility plus depression elevates risk for heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 Pamela Bowen, Chief Information... finalist for the "Chief Innovation Officer" Appy ...e power of cloud computing. Appy Award recipients ...alesforce CRM or the Force.com platform in bringin...arketing, partner, service, support or IT organiza...
(Date:12/4/2009)...e pediatric cancers, particularly Ewing sarcomas a... to a new study published online December 4 in the...his study was undertaken because there is limited ...to 20 years) for pediatric cancer patients. , Ka...enter and Blood Disorders Service, Children,s Heal...
(Date:12/4/2009)...esearchers, from the School of Medicine,s Departme...ways by which products of lipid peroxidation and s...etabolized. The pathways were identified by a comb...is. The findings shed new light on the mechanism o...e, also known as "the date rape drug." The manuscr...
(Date:12/4/2009)...urism is a phenomenon that was started by people t...ice of dental work in the US, Canada, and other co...are, people have found that Mexican Dental Vacatio...n. , (PRWEB) December 4, ...ars, Mexican Dental Vacation is seeing their best ...
(Date:12/4/2009)...deral regulators to crack down on abuse of opioid ...y News) -- The makers of 24 different prescription...s with plans to curb the abuse of these opioid dru...nder pressure from U.S. Food and Drug Administrati... fatal overdoses that occur with these medications...
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2
...ter study shows that an experimental drug lowers p...r tumor growth in men with advanced prostate canc...led. The study, led by researchers at Memorial Slo...rostate cancer eventually build up resistance to t...
...res Renowned Translational Cancer Researchers and ...with Academic and Industry Leaders , , NEW YORK, ...ists will discuss the rapidly changing cancer rese...on Clinical Investigator Symposium. , , The Apr...
...s Sigma as they move from B2B to B2C, encouraging ... treatment. , , ORADELL, N.J., April 8 Sigma Gro...echnologies, the world leader in burn care product...ields and hospitals directly to consumer household...
...April 8 Dialysis Corporation of America (Nasdaq: ...a grant agreement with the University of Cincinna...ll total $265,000 each year, for the next three ye...ration of America a platform from which to support...
...nn. -- A new study conducted at Mayo Clinic report...oses of certain drugs for Parkinson,s disease deve... notably compulsive gambling or hypersexuality. , ...lable on the Mayo Clinic News Blog. , The study ...
... 8, 2009) Middle school youth are engaging in sex... study by researchers at The University of Texas S...y are published in the April issue of Journal of ...ual risk behaviors among middle school students in...
Other Medicine News:Health News:Drug shows activity in men with advanced prostate cancer 2Health News:Drug shows activity in men with advanced prostate cancer 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 2Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 4Health News:Sigma is Named AOR for Water-Jel Technologies, The World Leader in Burn Care Products 2Health News:Dialysis Corporation of America Announces Establishment of Clinical Grant Agreement with the University of Cincinnati, College of Medicine 2Health News:Parkinson's disease medication triggers destructive behaviors 2Health News:Middle school youth as young as 12 engaging in risky sexual activity 2
(Date:12/4/2009)..., Md., Dec. 4 Drs. Neal Shore and ...pecific antigen (PSA) recurrence from the addition... recurrence rate in a Phase III pivotal study of F... monthly leuprolide in prostate cancer patients du... patients who received FIRMAGON 240/80 mg/month ha...
(Date:12/3/2009)...RK, Dec. 3 Guidepoint Global, LLC...d the launch of their Sleep Apnea Tracker, a month...jects trends and market share in the worldwide Sle...ptures actual patient usage for 87 different Sleep...15 different equipment providers going back to Jan...
(Date:12/3/2009)...ALE, Calif., Dec. 3 Phar...cal company focused on developing and commercializ...ent of immune mediated diseases and cancer, today ...ce call on, Tuesday, December 8, 2009 at 11:00am E...ic Time) to discuss clinical data regarding its HD...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Waiting Wondering About Radiology Results Irks Patients 60703 1Waiting Wondering About Radiology Results Irks Patients 60703 2Shorter More Intense Radiation OK for Some Breast Cancers 60701 1Shorter More Intense Radiation OK for Some Breast Cancers 60701 2Shorter More Intense Radiation OK for Some Breast Cancers 60701 3Does race income predict prostate cancer outcome 3F 60699 1Does race income predict prostate cancer outcome 3F 60699 2
Kelly Descemet's Membrane Punch
Optec 3500 Vision Tester
Stainless Steel Ruler
Colorado Needle
Medicine Products: